bladder cancer

Videos

Real-World Survival Trends in Muscle-Invasive Bladder Cancer and Urothelial Carcinoma

03/12/2021

Nimira Alimohamed, MD, discusses results from a real-world analysis of outcomes over time in patients with muscle-invasive bladder cancer and patients with metastatic urothelial carcinoma.

Nimira Alimohamed, MD, discusses...

03/12/2021

Journal of Clinical Pathways

Videos

Neoadjuvant Immune Checkpoint Inhibitors Unlikely Cost-Effective for Muscle-Invasive Bladder Cancer

02/25/2021

Journal of Clinical Pathways

Videos

Pembrolizumab Unlikely Cost-Effective for BCG-Unresponsive Bladder Cancer in US

02/17/2021

Journal of Clinical Pathways

Research Reports

The Real-World Lifetime Economic Burden of Urothelial Carcinoma by Stage at Diagnosis

05/19/2020

Abdalla Aly, PhD

Courtney Johnson, MPH

Yunes Doleh, MPH, PharmD

Viktor Chirikov, MS, PhD

Marc Botteman, MSc

Rahul Shenolikar, MS, PhD

Arif Hussain, MD

Abstract: Urothelial carcinoma (UC) is generally diagnosed early and may incur significant lifetime costs. This study estimated, from the payer’s perspective, the lifetime costs among patients diagnosed with UC...

...

05/19/2020

Journal of Clinical Pathways

Research Reports

Costs of Care for Patients Receiving Chemotherapy for Advanced Bladder Cancer

12/13/2017

Ashish M Kamat, MD, MBBS

Xiting Cao, PhD

Jinghua He, PhD, MPH

Yichen Zhong, MPH

Amishi Y Shah, MD

Kyle Flannery, PharmD, MS

12/13/2017

Journal of Clinical Pathways

Gemcitabine-Based Chemoradiation Effective Bladder Cancer Treatment for Underdeveloped Nations

06/04/2017

JCP Editors

Neoadjuvant gemcitabine-based chemotherapy, followed by gemcitabine-based concomitant chemoradiation, may aid in bladder preservation for patients receiving treatment for muscle-invasive bladder cancer in...

...

06/04/2017

Journal of Clinical Pathways

Real-World Data Shows Metastatic Bladder Cancer Survival Worse Than in Clinical Trials

05/31/2017

JCP Editors

Few patients with metastatic urothelial carcinoma of the bladder are surviving as long in the real-world as those in clinical trials, according to new research. Current overall survival projections for patients with...

Few...

05/31/2017

Journal of Clinical Pathways

Guideline-Recommended Therapy Underused in Rare Form of Bladder Cancer

05/16/2017

JCP Editors

Recommended primary treatment for non-muscle invasive micropapillary urothelial carcinoma (MPBC) is often foregone in community cancer centers and academic centers, according to a study presented at the American...

...

05/16/2017

Journal of Clinical Pathways

Research in Review

Pembrolizumab Better Than Chemotherapy for Urothelial Cancer

11/14/2016

JCP Editors

An anti-PD-1 therapy significantly improves overall survival (OS) compared with chemotherapy in previously treated patients with advanced bladder (urothelial) cancer, according to a study presented at the Society for...

An...

11/14/2016

Journal of Clinical Pathways

Nivolumab Effective for Advanced Bladder Cancer

06/07/2016

JCP Editors

Nivolumab may help to significantly reduce tumor burden in patients with metastatic bladder cancer, regardless of whether their tumors have a biomarker related to the drug’s target, according to clinical trial...

...

06/07/2016

Journal of Clinical Pathways